Physician profile
Melissa Hatter
NPI 1275897399
$2,034.00
in general payments reported to CMS, 2019-2025
14 companies · $21.92 in 2025
The $21.92 reported for 2025 was less than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $222 · 2022: $162 · 2023: $231 · 2024: $1,397 · 2025: $21.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,323 · Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,323.00 |
| Food and Beverage | $327.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,323.00 | 2024 | |
| Abbvie INC. | $259.94 | 2021-2023 | |
| Myriad Women'S Health, INC. | $127.19 | 2023 | Myrisk |
| Coopersurgical, INC. | $69.89 | 2021-2024 | Paragard T 380a, Summit Doppler |
| Pfizer INC. | $60.25 | 2022-2024 | |
| Hologic Sales and Service, LLC | $56.46 | 2022-2024 | Aptima |
| Sage Therapeutics, LLC | $24.42 | 2024 | |
| Minerva Surgical, INC | $21.92 | 2025 | |
| Sumitomo Pharma America, INC. | $20.06 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $15.10 | 2021 | |
| Myovant Sciences INC. | $14.90 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.72 | 2021 | |
| Scynexis, INC. | $14.42 | 2022 | |
| Therapeuticsmd, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Hatter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.